77 related articles for article (PubMed ID: 2621443)
1. Monoclonal antibodies reacting with the exopolysaccharide xanthan from Xanthomonas campestris.
Haaheim LR; Kleppe G; Sutherland IW
J Gen Microbiol; 1989 Mar; 135(3):605-12. PubMed ID: 2621443
[TBL] [Abstract][Full Text] [Related]
2. The production of hybridoma cell line secreting monoclonal antibodies against Xanthomonas campestris pv. oryzae and its application in the classification of strains.
Huang B; Zhu H; Hu G; Li Q; Gao J; Liu S
Chin J Biotechnol; 1992; 8(2):139-44. PubMed ID: 1284289
[TBL] [Abstract][Full Text] [Related]
3. Production of novel monoclonal antibodies against rabbit platelet factor four.
Cazzola F; Saggin L; Callegaro L
Hybridoma; 1992 Feb; 11(1):61-9. PubMed ID: 1737641
[TBL] [Abstract][Full Text] [Related]
4. Production and partial characterization of monoclonal antibodies to Pasteurella haemolytica A1 capsular polysaccharide and lipopolysaccharide.
Penaredondo MV; Maheswaran SK; Whiteley LO; Ames TR; Leininger JR
Am J Vet Res; 1988 Nov; 49(11):1962-8. PubMed ID: 2470277
[TBL] [Abstract][Full Text] [Related]
5. Generation of a novel high-affinity monoclonal antibody with conformational recognition epitope on human IgM.
Sarikhani S; Mirshahi M; Gharaati MR; Mirshahi T
Appl Biochem Biotechnol; 2010 Nov; 162(5):1249-57. PubMed ID: 20162378
[TBL] [Abstract][Full Text] [Related]
6. Functional characterization of GumK, a membrane-associated beta-glucuronosyltransferase from Xanthomonas campestris required for xanthan polysaccharide synthesis.
Barreras M; Abdian PL; Ielpi L
Glycobiology; 2004 Mar; 14(3):233-41. PubMed ID: 14736729
[TBL] [Abstract][Full Text] [Related]
7. The genome of Xanthomonas campestris pv. campestris B100 and its use for the reconstruction of metabolic pathways involved in xanthan biosynthesis.
Vorhölter FJ; Schneiker S; Goesmann A; Krause L; Bekel T; Kaiser O; Linke B; Patschkowski T; Rückert C; Schmid J; Sidhu VK; Sieber V; Tauch A; Watt SA; Weisshaar B; Becker A; Niehaus K; Pühler A
J Biotechnol; 2008 Mar; 134(1-2):33-45. PubMed ID: 18304669
[TBL] [Abstract][Full Text] [Related]
8. Genetic engineering of polysaccharide structure: production of variants of xanthan gum in Xanthomonas campestris.
Hassler RA; Doherty DH
Biotechnol Prog; 1990; 6(3):182-7. PubMed ID: 1366611
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of hybridomas producing monoclonal antibodies against human alpha interferon.
Novák M; Borecký L; Kontseková E; Kontsek P; Nováková M
Acta Virol; 1986 May; 30(3):228-33. PubMed ID: 2874727
[TBL] [Abstract][Full Text] [Related]
10. Influence of agitation and aeration in xanthan production by Xanthomonas campestris pv pruni strain 101.
Borges CD; da Moreira AS; Vendruscolo CT; Ayub MA
Rev Argent Microbiol; 2008; 40(2):81-5. PubMed ID: 18705486
[TBL] [Abstract][Full Text] [Related]
11. Production of monoclonal antibodies to Pseudomonas syringae pv. phaseolicola and Xanthomonas campestris pv. phaseoli.
Wong WC
Lett Appl Microbiol; 1990 Jun; 10(6):241-4. PubMed ID: 1367453
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody which has the neutralizing activities for human IL-2.
Sato H; Natsuume-Sakai S; Miyawaki T; Taga K; Hatano M; Taniguchi N
J Biol Response Mod; 1986 Apr; 5(2):191-201. PubMed ID: 3488373
[TBL] [Abstract][Full Text] [Related]
13. Production of monoclonal antibodies against Xanthomonas campestris pv. mangiferaeindicae and their use to investigate differences in virulence.
Sanders GM; Verschoor JA; van Wyngaard S; Korsten L; Kotzé JM
J Appl Bacteriol; 1994 Nov; 77(5):509-18. PubMed ID: 7528196
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies to Salmonella lipopolysaccharide: anti-O-polysaccharide antibodies protect C3H mice against challenge with virulent Salmonella typhimurium.
Colwell DE; Michalek SM; Briles DE; Jirillo E; McGhee JR
J Immunol; 1984 Aug; 133(2):950-7. PubMed ID: 6203984
[TBL] [Abstract][Full Text] [Related]
15. Murine tumor cell lysis by antibody-dependent macrophage-mediated cytotoxicity using syngeneic monoclonal antibodies.
Kawase I; Komuta K; Ogura T; Fujiwara H; Hamaoka T; Kishimoto S
Cancer Res; 1985 Apr; 45(4):1663-8. PubMed ID: 3978634
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies against genetically manipulated hepatitis B core antigen.
Hlozánek I; Korec E; Dostálová V; Stará J; König J; Bichko VV; Seichertová A; Gren EJ
Folia Biol (Praha); 1987; 33(5):295-300. PubMed ID: 3691895
[TBL] [Abstract][Full Text] [Related]
17. Systematic generation of antigen specific human monoclonal antibodies with therapeutical activities using active immunization.
Lang AB; Fürer E; Senyk G; Larrick JW; Cryz SJ
Hum Antibodies Hybridomas; 1990; 1(2):96-103. PubMed ID: 2129420
[TBL] [Abstract][Full Text] [Related]
18. Production and characterization of monoclonal antibodies against tissue-type plasminogen activator.
Ding H; Wang JY; Song HY
Chin J Biotechnol; 1990; 6(3):223-7. PubMed ID: 2129498
[TBL] [Abstract][Full Text] [Related]
19. Development of hybridoma cells producing monoclonal antibody against human epsilon (epsilon) chain.
Majidi J; Hassan ZM
Hum Antibodies; 2003; 12(3):93-8. PubMed ID: 14646037
[TBL] [Abstract][Full Text] [Related]
20. Sequential assembly and polymerization of the polyprenol-linked pentasaccharide repeating unit of the xanthan polysaccharide in Xanthomonas campestris.
Ielpi L; Couso RO; Dankert MA
J Bacteriol; 1993 May; 175(9):2490-500. PubMed ID: 7683019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
